I-Mab Receives IND Approval For Phase 1 Clinical Trial Of Bispecific Antibody TJ-CD4B in Solid…
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced that…